Vineet Laboratories (NSE:VINEETLAB) Debt-to-Equity: N/A (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VINEETLAB Vineet Laboratories Ltd NSE:VINEETLAB
38 GF Score
Price ₹39.75
GF Value ₹15.08
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Vineet Laboratories Debt-to-Equity?

Vineet Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was ₹0.0 Mil. Vineet Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was ₹0.0 Mil. Vineet Laboratories's Total Stockholders Equity for the quarter that ended in Dec. 2025 was ₹0.0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Vineet Laboratories's Debt-to-Equity or its related term are showing as below:

NSE:VINEETLAB' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.39   Med: 1.11   Max: 3.01
Current: 3.01

During the past 9 years, the highest Debt-to-Equity Ratio of Vineet Laboratories was 3.01. The lowest was 0.39. And the median was 1.11.

NSE:VINEETLAB's Debt-to-Equity is ranked worse than
97.26% of 1421 companies
in the Chemicals industry
Industry Median: 0.36 vs NSE:VINEETLAB: 3.01

Vineet Laboratories  (NSE:VINEETLAB) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Vineet Laboratories Debt-to-Equity Related Terms

Vineet Laboratories Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Vineet Laboratories's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vineet Laboratories Debt-to-Equity Chart

Vineet Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only 0.69 0.92 0.92 1.28 2.73

Vineet Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.60 2.73 2.86 3.01 N/A

NSE:VINEETLAB vs DOW: Debt-to-Equity Comparison

For the Chemicals subindustry, Vineet Laboratories's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vineet Laboratories Debt-to-Equity vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vineet Laboratories's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Vineet Laboratories's Debt-to-Equity falls into.


NSE:VINEETLAB
38GF Score
Vineet Laboratories Ltd NSE:VINEETLAB
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vineet Laboratories Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Vineet Laboratories's Debt to Equity Ratio for the fiscal year that ended in Mar. 2025 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(362.612 + 37.859) / 146.476
=2.73

Vineet Laboratories's Debt to Equity Ratio for the quarter that ended in Dec. 2025 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued. The current stock price of ₹39.75 is trading 163.6% above its estimated GF Value™ of ₹15.08. GuruFocus considers Vineet Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:VINEETLAB:

  • Debt-to-Equity: N/A
  • GF Value™: ₹15.08 vs. price of ₹39.75 (163.6% above fair value)
  • GF Score™: 38/100 with 9 warning signs

No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vineet Laboratories Business Description

Other Exchanges 543298:India
Address 5-5-160, Malleswari Nilayam, Chintalakunta, Opposite Vishnu Theatre, L.B Nagar, Hyderabad, TG, IND, 500074
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
38GF Score

Get the complete analysis for NSE:VINEETLAB

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹39.75
Price
₹15.08
GF Value